Associate Professor
Division of Gynecologic Oncology
Department of Gynecology and Obstetrics
Emory University School of Medicine
Phone: 404-616-3540
Fax: 404-521-3589
E-Mail: kault@emory.edu
Mailing Address: 69 Jesse Hill, Jr., Drive, S.E., Rm 406
Atlanta, GA 30303

Education
MD, Indiana University College of Medicine, Indianapolis, Indiana
Residency, Obstetrics and Gynecology, Ohio State University, Columbus, Ohio
Fellowship, University of Kansas Medical Center, Kansas City, Kansas, Division of Infectious Diseases

Board certifications
Diplomate, American Board of Obstetrics and Gynecology, 1995

Awards, honors, leadership positions 2007
Ella Grasso Memorial Lecture at Yale University
John Brewer Memorial Lecture, American College of Obstetricians and Gynecologists
Ray Kaufman Lecture, Texas Assocation of Obstetricians and Gynecologists
Fellow, Infectious Disease Society of America
Examiner, American Board of Obstetrics and Gynecology

Professional societies and memberships
Fellow, 1997 – Present, American College of Obstetricians and Gynecologists
1991 – Present, American Society for Microbiology
1995 – Present, International Infectious Disease Society for Obstetrics and Gynecology
1997 – Present, Infectious Diseases Society for Obstetrics and Gynecology
1999 – Present, International Society for STD Research

Research focus and special interests
Dr. Ault's research interests are infectious diseases and women's health. He is an investigator in vaccine trials for both herpes simplex virus and human papilloma virus. Additional research in the pathogenesis of infections due to Chlamydia and gonorrhea has been supported by the National Institutes of Health. Much of this research has been multidisciplinary. Currently he has pending NIH grant applications with an epidemiologist, a physiologist and an immunologist. His clinical interests include colposcopy and treatment of cervical dysplasia and management of vaginitis and sexually transmitted diseases in women.

References
Hollmer C, Essmann M, Ault KA and Larsen B. Adherence and Blocking of Candida albicans to Cultured Vaginal Epithelial Cells: Treatments to Decrease Adherence. Infectious Diseases in Obstetrics and Gynecology. 2006; Article ID 98218. (on line journal)

Villa LL, Ault KA, Giuliano AR, Costa RLR, Petta CA et al. Immunologic Responses following Administration of a Vaccine Targeting Human Papillomavirus Types 6, 11, 16, and 18. Vaccine 2006; 24:5571 – 5583.

Fraser C, Tomassini J, Xi L, Golm G, Watson M, Giuliano A, Barr E and Ault KA. Modeling the Long-term Antibody Response of a Human Papillomavirus (HPV) Virus-like Particle (VLP) Type 16 Prophylactic Vaccine. Vaccine 2007; 25:4324-4333.

Koutsky L and the FUTURE II Study Group (including Ault KA). Efficacy and safety of a prophylactic quadrivalent human papillomavirus (types 6/11/16/18) L1 virus-like-particle vaccine in the prevention of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a randomized controlled trial. N Engl J Med 2007; 356:1915-1927.

Ault KA and the FUTURE II Study Group. Prophylactic use of human papillomavirus (HPV) L1 virus-like particle vaccine significantly reduces cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ risk: a combined analysis of four efficacy trials. The Lancet 2007; 369:1861-1868.

faculty bios
R. Adam, MD
Y. Ahn, MD

J. Arluck, MD

K. Ault, MD

Mary S. Dolan, MD, MPH

T. Duong, MD

J. Ellis, MD, PhD

L. Flowers MD

J. Goedken, MD
K. Godwin, MD
V. Green, MD, MHSA, MBA, JD
R. Hatcher, MD

N. Sidell, PhD

D. Session, MD
C. Spann, MD
J. Spencer, MD

R. N. Taylor, MD PhD

S. Weiss, MD